Login / Signup

Dnmt1 has de novo activity targeted to transposable elements.

Chuck HaggertyHelene KretzmerChristina RiemenschneiderAbhishek Sampath KumarAlexandra L MatteiNina BaillyJudith GottfreundPay GiesselmannRaha WeigertBjörn BrändlPascal GiehrRené BuschowChristina GalonskaFerdinand von MeyennMelissa B PappalardiMichael T McCabeLars WittlerClaudia Giesecke-ThielThorsten MielkeDavid MeierhoferBernd TimmermannFranz-Josef MüllerJörn WalterAlexander Meissner
Published in: Nature structural & molecular biology (2021)
DNA methylation plays a critical role during development, particularly in repressing retrotransposons. The mammalian methylation landscape is dependent on the combined activities of the canonical maintenance enzyme Dnmt1 and the de novo Dnmts, 3a and 3b. Here, we demonstrate that Dnmt1 displays de novo methylation activity in vitro and in vivo with specific retrotransposon targeting. We used whole-genome bisulfite and long-read Nanopore sequencing in genetically engineered methylation-depleted mouse embryonic stem cells to provide an in-depth assessment and quantification of this activity. Utilizing additional knockout lines and molecular characterization, we show that the de novo methylation activity of Dnmt1 depends on Uhrf1, and its genomic recruitment overlaps with regions that enrich for Uhrf1, Trim28 and H3K9 trimethylation. Our data demonstrate that Dnmt1 can catalyze DNA methylation in both a de novo and maintenance context, especially at retrotransposons, where this mechanism may provide additional stability for long-term repression and epigenetic propagation throughout development.
Keyphrases
  • dna methylation
  • genome wide
  • gene expression
  • copy number
  • embryonic stem cells
  • single cell
  • single molecule
  • cancer therapy
  • optical coherence tomography
  • data analysis